ADAM19: A Novel Target for Metabolic Syndrome in Humans and Mice

<div>Neutralisation of ADAM19 reduces high fat diet induced obesity. Representative photographs of HFD-fed mice administered with either rabbit IgG (a) or ADAM19 neutralising antibody (b). Mice administered rabbit IgG possessed increased gonadal adipose tissue compared to mice administered ADAM19 neutralising antibody.</div>

Mediators of Inflammation

fig4

Figure 4

Figure 4: ADAM19: A Novel Target for Metabolic Syndrome in Humans and Mice 